Business
Bio Spectrum
Rubicon Research completes acquisition of Alkem's Pithampur unit for Rs 149 Cr
Rubicon Research has completed the acquisition of Alkem Laboratories’ formulations manufacturing facility in Pithampur, Madhya Pradesh in an all-cash deal for Rs 149 crore.
1 min |
August 2025
Bio Spectrum
Digital Personal Data Protection Act (DPDPA) – A Wake-Up Call for IVF Clinics
With the introduction of the Digital Personal Data Protection Act, 2023 (DPDPA), questions are being raised about how India's earlier medical laws handle patient data and privacy.
3 min |
August 2025
Bio Spectrum
Waters launches Xevo TQ Absolute XR Mass Spectrometer
Waters Corporation has announced the launch of the Xevo TQ Absolute XR Mass Spectrometer, the company's most sensitive, robust, and reliable benchtop tandem quadrupole.
1 min |
August 2025
Bio Spectrum
Next-generation surgical robotics stand poised for global revolution
The adoption of robot-assisted surgery has increased significantly in the past decade as opportunities for performing minimally invasive procedures have multiplied.
5 min |
August 2025
Bio Spectrum
Quantum Sensing and Healthcare: Charting India's Next Frontier
Quantum sensing can revolutionise healthcare by enabling early disease detection, precise diagnostics, and customized treatment plans. It detects subtle changes in fields, improving diagnoses for various diseases.
4 min |
August 2025
Bio Spectrum
Accelerated Reliance on Digital Animal Replacement Tech
While Europe is talking about non-animal replacement tests to be used for drug development and research purposes, US FDA is acting upon it with a detailed roadmap aimed at rapidly reducing animal testing in preclinical safety assessments. These developments clearly provide huge opportunities for global companies that are developing alternative methods such as organoids, 3D bioprinting, digital animal replacement technology, computer simulation, to name a few. But where does India stand in this regard, and how skilled are we to make this shift?
4 min |
August 2025
Bio Spectrum
How Can Labs Reduce Their Energy Consumption?
Research labs can concentrate on innovation by collaborating with infrastructure providers, leaving waste, water, and energy management to professionals.
2 min |
August 2025
Bio Spectrum
LogicFlo AI gets $2.7 M to scale AI agent workforce across global life sciences enterprises
Chennai-based startup LogicFlo AI, an artificial intelligence (AI) platform designed specifically for the life sciences sector, has raised $2.7 million in a seed round led by Lightspeed, with participation from leading healthcare and enterprise AI investors.
1 min |
August 2025
Bio Spectrum
Why the New Schedule M Is a Game Changer for Indian Pharma and How the Industry Is Adapting
The Indian pharmaceutical industry stands at a pivotal moment. With the government's notification of the revised Schedule M in January 2024, the sector is undergoing a structural and cultural transformation. The updated regulations, which bring India’s Good Manufacturing Practices (GMP) in line with global standards, are not just compliance mandates, they represent a paradigm shift towards consistent quality, operational excellence, and global competitiveness.
4 min |
BioSpectrum India July 2025
Bio Spectrum
“There is a huge gap in corporate engagement and government procurement of innovative products within Telangana”
According to the world’s leading real estate consulting firm, CNRE’s latest report, ‘Global Life Sciences Atlas’, Hyderabad has emerged as a prominent global centre of life sciences manufacturing activity in India. This positions Telangana to play a defining role in shaping the next decade of biotech innovation and entrepreneurship. In alignment with this development, Hyderabad-based Atal Incubation Centre (AIC), hosted in one of the premier research institutes, CSIR-Centre for Cellular and Molecular Biology (CCMB), seeks unique schemes and proposals from the government to strengthen biotech entrepreneurship in the state. Dr N. Madhusudhana Rao, Chief Executive Officer, AIC-CCMB, spoke with BioSpectrum India, highlighting the dynamic growth trajectory of the biotech innovation ecosystem in Telangana. Edited excerpts:
4 min |
BioSpectrum India July 2025
Bio Spectrum
Qiagen expands portfolio for minimal residual disease testing in oncology
Netherlands-based holding company Qiagen N.V. has announced the expansion of its oncology diagnostics portfolio with two strategic partnerships to advance the use of minimal residual disease (MRD) testing in clinical trials to support pharma co-development projects for companion diagnostics.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Thermo Fisher Scientific launches new Spectral Flow Cytometer
Thermo Fisher Scientific Inc. has launched the spectralenabled Invitrogen Attune Xenith Flow Cytometer, allowing immunology and immuno-oncology researchers to automate and streamline workflows to obtain more detailed and accurate insights from critical cellular samples.
1 min |
BioSpectrum India July 2025
Bio Spectrum
NIT Rourkela designs labelfree biosensor for affordable breast cancer diagnosis
Researchers at the National Institute of Technology (NIT) Rourkela, Odisha have investigated a novel semiconductor devicebased biosensor that can identify breast cancer cells without the need for complicated or expensive laboratory procedures.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Africa CDC, WHO, and RKI expand unique partnership to strengthen collaborative surveillance
The World Health Organization (WHO), Africa Centres for Disease Control and Prevention (Africa CDC) and the Robert Koch Institute (RKI) have announced the expansion of the successful Health Security Partnership to Strengthen Disease Surveillance in Africa (HSPA) to seven countries on the continent.
1 min |
BioSpectrum India July 2025
Bio Spectrum
P. D. Hinduja Hospital, King's College London commence first training programme for nurses
P. D. Hinduja Hospital & Medical Research Centre has entered into a strategic services agreement with King's College London, Guy's and St Thomas' NHS Foundation to deliver training in clinical and non-clinical courses for doctors and nurses, research capacity building and executive education to health professionals in India and the UK.
1 min |
BioSpectrum India July 2025
Bio Spectrum
How genomic revolution is reshaping healthcare in emerging markets
A new frontier in medicine, powered by genomics, is unfolding across emerging economies, promising to transform healthcare landscapes from Egypt to China. The application of genomics in healthcare offers a multi-pronged approach to improving public health, from proactive prevention to highly targeted treatments. The benefits are vast and interconnected, creating a powerful ecosystem for medical innovation. Let's explore further.
5 min |
BioSpectrum India July 2025
Bio Spectrum
VFL Sciences partners with Cytosurge AG to bring FluidFM OMNIUM platform to India
Chennai-based VFL Sciences has entered a partnership with Cytosurge AG to offer the FluidFM OMNIUM platform, a semi-automated single-cell manipulation system for non-destructive injection and extraction, compatible with single-cell RNA analysis and advanced gene editing techniques.
1 min |
BioSpectrum India July 2025
Bio Spectrum
How Immune Cell and Gene Therapies are Transforming Treatment in India.
Immune cell and gene therapies are redefining treatment for cancer, genetic disorders, and autoimmune diseases in India. Once considered the realm of science fiction, these living medicines are now at the forefront of clinical care, offering hope for previously untreatable or poorly managed conditions.
4 min |
BioSpectrum India July 2025
Bio Spectrum
Ayush Ministry launches.portal to address issues of adverse drug reaction
In a landmark step toward strengthening consumer protection and regulatory oversight in the field of traditional medicine, the Union Minister of State (Independent Charge), Ministry of Ayush; and Union Minister of State, Ministry of Health & Family Welfare, Government of India, Prataprao Jadhav, recently launched the AyushSuraksha Portal.
1 min |
BioSpectrum India July 2025
Bio Spectrum
"We see India not just as a trade partner, but as a strategic collaborator for the US market and beyond"
Ella Woger-Nieves, Chief Executive Officer of Invest Puerto Rico, spoke BioSpectrum India on the sidelines of BIO 2025, offering insights into how Puerto Rico has firmly positioned itself as the leading pharmaceutical exporter in the United States. With $54.3 billion in annual life sciences exports to over 120 countries, the island is leveraging its strategic location, FDA-aligned manufacturing ecosystem, and robust talent base to attract global biopharma investments. In this interaction, Ella Woger-Nieves discusses Puerto Rico’s infrastructure, policy incentives, global outreach including recent engagements in India, and its long-term vision as a hub for next-generation therapeutics. Edited excerpts;
4 min |
BioSpectrum India July 2025
Bio Spectrum
WHO outlines recommendations to protect infants against RSV
The World Health Organization (WHO) has published its first-ever position paper on immunisation products to protect infants against respiratory syncytial virus (RSV) the leading cause of acute lower respiratory infections in children globally.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Nitika Pharmaceutical strengthens indigenous manufacturing of complex excipients
The Technology Development Board (TDB), Department of Science and Technology (DST), Government of India has extended financial support to Nitika Pharmaceutical Specialties in Nagpur, for their project titled \"Manufacture of Complex Excipients.\"
1 min |
BioSpectrum India July 2025
Bio Spectrum
Sharda Care Healthcity ropes in Dr Chirag Tandon as Director of Internal Medicine
Reinforcing its leadership in comprehensive internal medicine and integrated patient care, Sharda Care Healthcity has appointed renowned physician Dr Chirag Tandon as Director of the Department of Internal Medicine at its state-of-the-art facility in Greater Noida.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Shivtek Spechemi Industries invests Rs 600 Cr to set up new unit in Gujarat
Leading speciality chemicals manufacturer, Shivtek Spechemi Industries, a flagship company of the Shiva Group of Industries, focusing on innovation, sustainability, and high-quality solutions for pharmaceuticals, agrochemicals, and industrial coatings, has announced the finalisation of a new manufacturing facility near Hazira, spread across 1 million+ square feet.
1 min |
BioSpectrum India July 2025
Bio Spectrum
IKP Knowledge Park inks MoU with BITS Pilani Hyderabad to support startups
IKP Knowledge Park had announced the signing of a Memorandum of Understanding (MoU) with BITS Pilani Hyderabad Campus TBI Society (TBIS), a strategic collaboration to strengthen the innovation and technology transfer ecosystem.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Marengo Asia Hospitals strengthens orthopaedic leadership
Marengo Asia Hospitals' flagship unit, Marengo CIMS Hospital in Ahmedabad, has announced the strengthening of their orthopaedic leadership with the onboarding of world-renowned orthopaedic surgeon Dr K. C. Mehta as Director - Orthopaedics and Joint Replacement, Marengo CIMS Hospital, Ahmedabad.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Novo Nordisk Foundation enters into strategic framework agreement with WHO to advance global health
Novo Nordisk Foundation has entered into a strategic framework agreement with the World Health Organization (WHO) to advance global health.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Centre opens investor facilitation portal for traditional medicine sector
The Government of India has launched the Ayush Nivesh Saarthi portal, a dedicated, investor-centric digital platform developed by the Ministry of Ayush in collaboration with Invest India.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Can Indian Companies Compete with MNCs in GLP-1 Production?
With the patents for blockbuster diabetes and obesity drugs, particularly Semaglutide set to expire in India in March 2026, it is expected to trigger a major shift in the market. Indian pharmaceutical companies will be able to launch generic versions of these high-demand GLP-1 receptor agonist drugs. This is a pivotal moment in the offering that will democratise access to expensive therapies that has been till now dominated by multinational companies.
9 min |
BioSpectrum India July 2025
Bio Spectrum
Agenus and Zydus Lifesciences enter $141 M strategic collaboration for biologics manufacturing in US
US-based Agenus Inc., a leader in immuno-oncology innovation, has signed definitive partnership agreements with Ahmedabad based Zydus Lifesciences, including its subsidiaries/ affiliates, designed to accelerate clinical development, scale global manufacturing, and expand patient access to botensilimab and balstilimab (BOT/BAL).
1 min |